MENU
Advertisement
Show Filters
Refine by Content Type
Refine by Year
Sort By:
Choose Sites to Search:
Sponsored by CeloNova BioSciences, Inc.
Clinical Decision-Making for PCI Patients During the COVID-19 Pandemic
With Aloke Finn, MD; Rajiv Jauhar, MD, FACC, FSCAI; and S. Jay Mathews, MD, MS, FACC
Magenta Medical’s Elevate Early Feasibility Study Completes Enrollment
August 31, 2023—Magenta Medical recently announced the completion of enrollment to its FDA-approved early feasibility study (EFS) with the company’s Elevate percutaneous left ventricular assist device (pLVAD) for the high-risk percutaneous coronary intervention (HR-PCI) indication.
